About RTLGenomics
RTLGenomics is a company based in Lubbock (United States) founded in 2007 was acquired by MicroGen Diagnostics in June 2021. RTLGenomics offers products and services including Next Generation Sequencing, Bioinformatics, and Sample Preparation. RTLGenomics operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Lubbock, United States
- SectorsHealthcare
- Website rtlgenomics.com
- Social LinkedIn X Facebook
- Acquired by MicroGen Diagnostics (Jun 2021)
- Legal Name Research And Testing Laboratories, Llc
- Investors
- Acquired byMicroGen Diagnostics
(Jun 2021)
Products & Services of RTLGenomics
RTLGenomics offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Bioinformatics, and Sample Preparation.
Provides DNA sequencing using Illumina platforms for research needs.
Delivers analysis and biostatistics for sequencing data interpretation.
Handles extraction and library preparation for sequencing projects.
Investors in RTLGenomics
RTLGenomics has secured backing from 1 investor. Prominent investors backing the company include MicroGen Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sequencing and molecular diagnostic services are provided for microbial detection. | 2011 | microgendx.com | Orlando, United States |
Investor details for RTLGenomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of RTLGenomics
2 dated milestones of RTLGenomics across 14 years, from founding to its latest funding, stage changes and deals.
- Founded RTLGenomics is founded.
- Exit Acquired by MicroGen Diagnostics.
Competitors of RTLGenomics
RTLGenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. | |
| solexa.com | 1992 | Hayward, United States | $14.4M | – | Develops Genome sequencing technology | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. |
Detailed competitors of RTLGenomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rtlgenomics
Complete news archive for RTLGenomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to RTLGenomics
10 companies that operate in the same segment as RTLGenomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RTLGenomics
RTLGenomics was founded in 2007.
RTLGenomics is headquartered in Lubbock, United States. It is registered at Lubbock, Texas, United States.
Provider of recombinant protein production and gene therapy. The company offers next-generation sequencing, bioinformatics, and biostatistics service for metagenomics (eDNA, microbial diversity analysis, diet analysis, environmental biodiversity, and MHC diversity), genomic profiling of model and non-model organisms by UCE analysis, ddRAD-seq, and WGS and de novo assembly, transcriptomics, and clinical diagnostics (via their CAP-certified sister company PathoGenius Labs).
RTLGenomics's top competitors include Novogene Corporation, BGI and Source BioScience.
RTLGenomics offers Next Generation Sequencing, Bioinformatics, and Sample Preparation.
RTLGenomics has 1 investor. Key investors include MicroGen Diagnostics.
RTLGenomics operates through Research And Testing Laboratories, Llc.
Yes. RTLGenomics was acquired by MicroGen Diagnostics in June 2021.